MDGL Stock Price
Madrigal Pharmaceuticals, Inc.
$449.74
-$10.07(-2.19%)
31
Overall
40
Value
9
Tech
44
Quality
Market Cap
$10.39B
Volume
364.53K
52W Range
$393.61 - $615.00
Target Price
$675.50
MDGL stock price is $449.74 (-2.19% on the day), giving Madrigal Pharmaceuticals, Inc. a market cap of $10.39B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
MDGL Stock Overview
- Price
- $449.74
- Previous close
- $459.81
- Open
- $459.57
- Market cap
- $10.39B
- P/E ratio
- -36.0
- 52-week range
- $393.61 - $615.00
- 1-year price target
- $675.50
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NGS
- MarketXLS Rank
- 31
About Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. The company offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company is headquartered in West Conshohocken, Pennsylvania.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MDGL | $449.74 | -2.2% | 364.53K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Madrigal Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW